🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

journals.lww.com/annalsofsurger…

ars.els-cdn.com/content/image/…

Q4: With evolving BMT, will asymptomatic revascularization become obsolete? How do we optimize training of comprehensive carotid management while maintaining appropriateness of care? #jvscitXchat Steven Maximus KatDiLosaMD @rmotagsanahalli Caitlin Hicks MD, MS Mahmoud Malas,MD,MHS

Super proud of Dr. Elsie Ross Elsie Ross Associate Professor of Vascular Surgery In-Residence UC San Diego Surgery for securing funding of her R-01 using #Al for early Detection of Peripheral Artery Disease (AID-PAD)

Proud to be part of the new Center for Healthcare Cybersecurity UC San Diego Health Sciences! Thank you Drs. Tully and Dameff for your leadership in this important space 🖥️ 🏥

Superb presentation Nishi Vootukuru Vascular SVS #VAM24 significant number of bedridden/wheelchair asymptomatic patients undergoing CEA with 2.6folds increase 30day death risk compared to ambulatory patients. These patients are better off with BMT UC San Diego Surgery

Kicking off day 2 of #VAM24 Kate McGinigle, MD MPH shares stratified analysis in BEST-CLI Trial. Females had lower MALE with any open conduit SSGSV + alternative conduits compared to endo, and lower rates of major amputation compared to males.

Very comprehensive presidential address Joseph L. Mills MD emphasizing numerous remarkable achievements by Society for Vascular Surgery #VAM24 proud to be a vascular surgeon and a member of our society

Excited to announce our vascular faculty recruitment UC San Diego Surgery Humbled by our team’s accomplishments: matured 0/5 residency, >10,000 accredited vasc lab studies/yr, AAHC accredited OBL, CLEVER with 40 pubs/yr, IDE, and home of vascular RO1! apol-recruit.ucsd.edu/JPF04073

Thanks Mike for posting our work. Always try to confirm my bias and anecdotal experience with the best possibly designed study. Clearly not level 1 evidence but confirm what many of us have experience. No staples allowed on my patients following LE bypass

Excellent presentation by Mo Hamouda at The Southern Association for Vascular Surgery presenting outcomes of CKD patients in the BEST-CLI trial, <50% 3-yrs survival in patients on dialysis. GFR<30 , based on spline model, predicts worse outcomes BEST-CLI Trial UC San Diego Surgery Society for Vascular Surgery

Excellent attendance The Southern Association for Vascular Surgery despite the gorgeous beaches and amazing weather at St. Thomas USVI. Good discussion of UC San Diego Surgery superb analysis by Dr Narek Veranyan showing that additional branch intervention reduces risk of mortality in pts with TBAD with malperfusion

Ann Gaffey, M.D., M.S., is passionate about her research and meaningful patient relationships. Outside of surgery, she enjoys sailing and mountain biking. #UCSDSurgery #HumansofSurgery #Vascular #Endovascular 🔗: surgery.ucsd.edu/people/humans-…

Confirming my bias. I send patients home if they did not take the P2Y12 inhibitor we prescribed to take at least five days prior to TCAR or TFCAS. Don’t load

Excited to take on this new role. Hopkins Surgery has so many amazing faculty doing very exciting work, and I hope we can continue to grow that. Thanks Andrew Cameron James H Black, MD for the opportunity!

Next up: Dr. Mahmoud Malas,MD,MHS presents "Bypass Versus Endovascular Therapy for Elective Infrapopliteal Interventions in Chronic Limb-Threatening Ischemia: Propensity Score-Matched Analyses of Vascular Quality Initiative Registry"🦵#AmerSurg25

Welcome to #VAM2025 #VAM25! Here is the first of our Simultaneous Presentation and Publication #Simulpub articles! 1 Year Outcome of TAMBE. bit.ly/4dEALOl

Great attendance #vam2025 strong work Ahmed H Abdelkarim presenting optimal timing >3mos to stage bilateral carotid revasc procedures UC San Diego Health UC San Diego Surgery